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Abstract
Background: Prostate cancer causes the highest number of cancer-related deaths in Jamaican men. It is not
known whether rural-dwelling men present with worse disease than urban-dwelling men at initial presentation.
Since rural and urban-dwelling Jamaicans are predominantly of African descent and generally similar in respect of
racial composition, if any significant variation in initial presentation were found, it would suggest that these are
likely due to differences in awareness, access to care, and screening patterns.
Methods: The medical records of rural and urban-dwelling patients with prostate cancer were compared. Patients’
age at presentation, initial prostate-specific antigen level, digital rectal examination findings, biopsy Gleason scores
and initial treatment received were compared using bivariate and logistic regression analyses.
Results: In unadjusted analyses rural-dwelling men were older compared to urban-dwelling men (72 years
versus 68.5 years, p = 0.035), had higher median PSA values (22.9 ng/ml versus 18 ng/ml, p = 0.001), higher local
tumour stage (65.2 % versus 34.8 % T3 disease; 73.7 % versus 26.3 % T4 disease; p = 0.005), higher mean
Gleason scores (p = 0.048) and more non-curative initial treatments. Local tumour stage was the only
statistically significant difference between rural and urban-dwelling men in logistic regression analysis with
rural-dwelling men having a 70 % higher risk of locally-advanced disease (OR = 1.70, 95 % CI: 1.03-2.79; p = 0.038).
Conclusion: Rural-dwelling men presented with more advanced prostate cancer compared to urban-dwelling men. As
both rural and urban-dwelling men are of predominant African descent it is likely that these differences are due to
differences in access to care, screening practice and awareness of the disease.
Keywords: Prostate cancer, Black men, African American, Rural population, Urban population, Health services
accessibility, Awareness, Early detection of cancer, Health disparities
Background
Caribbean men with prostate cancer (PCa) have their dis-
ease diagnosed at a later stage and suffer a worse outcome
compared to US born men of Afro-Caribbean descent [1].
Disparities in prostate cancer incidence and mortality
have been attributed to different factors by a number
of authors. In comparing outcomes of PCa treatment
in African American (AAM) and Afro-Caribbean men
(ACM) with Caucasian American men (CAM), being
of African descent was found to be an independent
predictor of a worse survival [2]. It was reported based
on an analysis of the Surveillance, Epidemiology and End
Results (SEER) database in the United States that only 29 %
of the disparity in the incidence of metastatic PCa between
AAM and CAM was explained by differences in PCa
screening practice, comorbidities and income; and none of
the disparity in loco-regional disease, suggesting biological
factors related to race may be more important [3].
Others have found that factors primarily related to in-
equities in access to medical care such as distance to
a urologist [4], physician recommended treatment-
related disparities wherein Black men receive less ag-
gressive stage and age inappropriate treatment [5],
lack of insurance and low household income are some
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of the socially determined factors to be blamed [6]. It
is likely that both biological factors related to African
descent as well as social/environmental factors are
important in explaining PCa disparities.
Jamaica, a country comprised primarily of persons of
African descent, has high recorded PCa incidence and
mortality rates for its metropolis, Kingston and St. Andrew
(KSA). Age-standardised incidence and mortality rates have
been reported at 78.1/100,000/year [7] and 53.9/100,000/
year [8] respectively. The clinico-pathologic profiles of
Jamaican men with PCa accessing private urologic care and
care at one of two tertiary care hospitals in the KSA
metropolis have been described but the distribution of their
profiles according to rural or urban residence was not
reported [9, 10]. A lack of information on the clinico-
pathologic profiles of rural versus urban-dwelling Jamaican
men with PCa therefore exists.
In Jamaica there is no formal national screening policy
for PCa [11] and men often present with advanced and
symptomatic disease [12]. In one series 80 % of Jamaican
men had symptomatic disease at presentation [9]. The
usual pathway to diagnosis of PCa for the majority of
Jamaican men is through referral to a urologist at a public
hospital or one in private practice after being first seen for
symptomatic disease at a health centre or general practi-
tioner. A median prostate-specific antigen (PSA) level of
30.7 ng/ml for incident cases of PCa in Jamaica was
reported with almost a third of men having a PSA level
greater than 100 ng/ml [10].
While there are no significant differences in the pre-
dominant African heritage of Jamaicans within rural
and urban settings, major differences may exist in ready
access to medical care and medical information. For
example, specialized urological services are more available
in urban settings with tertiary care facilities and access to
internet-based sources of information is less in rural areas.
If access and awareness are critical determinants in PCa
presentation and prognosis, then significant differences
would be expected in the clinico-pathologic profiles of
rural versus urban men. We therefore compared the initial
clinico-pathologic profiles and treatments of rural and
urban-dwelling men with PCa seen in private health care
settings at initial presentation.
Methods
The medical records of all men, whether still living or
deceased, diagnosed with PCa from two private urologists’
offices were reviewed. One urologist was based in the
country, in the south-western part of the island, while the
other was based in Kingston but saw patients on a
fortnightly basis in the south-western region of Jamaica
as well. The study was approved by the Ethics commit-
tee of the University of the West Indies.
Cases were men with histologically confirmed PCa
or men with overwhelming clinical, biochemical and/
or radiological evidence of PCa who did not undergo
biopsy but were presumed to have the disease. The lat-
ter comprised less than 1 % of cases and invariably
had PSA levels > 500 ng/ml.
Information on patients’ age, address, date at presenta-
tion, initial PSA level, local tumour stage based on digital
rectal examination (DRE) findings, biopsy Gleason score
and initial treatment received were extracted from the
patients’ files. The records spanned a 12 year period from
1999 to 2011.
Setting
Although urban is defined by the Statistical Institute of
Jamaica (STATIN) as a place that “has a population of
2000 or more persons and provides a number of amenities
and facilities which in Jamaica indicates modern living”, for
the purpose of this study only cities and capitals of parishes
were considered urban. The capital city of Jamaica, the lar-
gest urban centre, is located within the geographic bound-
aries governed by the municipal authority of the parishes of
Kingston and St. Andrew (KSA) found in the south-eastern
part of the island and has a population of 670,000 people.
It has two tertiary-level care public hospitals and 12
urologists.
The designation ‘rural’ was applied to patients residing
outside of named capital towns and cities in the
south-western part of Jamaica which was one of the
two study settings.
One urologist practices solely in the south-western
region of the island, a country area comprised of 4
parishes – Westmoreland, St. Elizabeth, Manchester
and Clarendon with a combined population of 738,000
people (Fig. 1). He is the only fixed practicing urologist
in this region. His practice is comprised of 3 locations,
Junction (St. Elizabeth), Mandeville (Manchester) and
May Pen (Clarendon). Mandeville and May Pen are the
capital towns for their respective parishes of Manchester
and Clarendon and are considered urban centres. Junction
is a small non-capital town in the parish of St. Elizabeth
and is considered rural for the purpose of this study.
The south-western region of the island consists of many
rural villages and extremely remote areas with very hilly
terrain. The majority of patients accessing private urological
care for prostate cancer from this region of the island
would be seen by the fixed country urologist.
A minority of country patients may be managed by
general surgeons, opt to go to a city-based urologist in
Kingston or Montego Bay, or may be seen by itinerant
urologists who travel from Kingston to the country on
an infrequent basis.
The city-based urologist practices in Kingston and
May Pen, the latter being the capital town for the parish
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Clarendon and therefore an urban centre, situated in the
mid-southern portion of the island (Fig. 1) where he sees
patients fortnightly. Patients seen by both urologists in the
country offices may be from either urban or rural settings.
Patients from the country seen in Kingston by the
Kingston-based urologist were excluded from the analysis.
Clinical and pathologic assessments
Both urologists used the AJCC TNM staging system to
assess local prostate tumour stage clinically on DRE.
However, because of slight differences in the classification
of the sub-categories of T2 based on the 1992 versus the
2003 TNM staging systems, only general T categories (T2,
T3 and T4) and T1c were used in the analysis to minimise
misclassification errors. PSA levels done in KSA were done
by one of three medical laboratories while those outside of
Kingston and St Andrew were done by a limited number of
medical laboratories inclusive of the same three laboratories
in Kingston which had branches in the country.
Most prostate biopsies done in KSA were done by a sin-
gle radiologist under transrectal ultrasound guidance taking
a minimum of 12 to 16 cores. Prostate biopsies outside
of KSA were mostly done under transrectal ultrasound
guidance but men with palpable, locally advanced tumours
(T3 and T4) commonly had finger-guided biopsies, taking
fewer cores in the process. Specimens from KSA were eval-
uated by a single pathologist in almost all cases and this
was the same for outside of KSA.
Analyses
The clinico-pathologic features of men with prostate
cancer from urban and rural areas were described using
summary tables. As appropriate, means of the two groups
were compared using the Student’s t-test, median PSAs
were compared with the Wilcoxon rank-sum test. Clinical
T stage was re-categorised into 2 groups organ-confined
(T1 and T2) and locally-advanced (T3 and T4) disease
and associations with geographic location determined
using Pearson’s chi squared test. P-values of <0.05 were
deemed statistically significant.
Regression analysis was also done to control for con-
founding and identify independent predictor variables for
rural–urban status. The variables included in the regression
analysis were those associated with rural/urban location in
bivariate analyses. The outcome ‘rural’ and ‘urban’ was
coded as one and zero respectively. Potential independent
variables identified through bivariate analysis were entered
in the model. For logistic regression Gleason scores were
recoded as 5–6 ‘low’, 7 ‘intermediate’ and 8–10 ‘high’. DRE
stage was converted to a binary variable with Stages T1c
and T2 being combined as ‘organ-confined disease’ and
Stages T3 and T4 being ‘locally-advanced disease’ (i.e.
disease extending beyond the prostatic capsule).
The Statistical Package for the Social Sciences (SPSS)
version 17 was used for the analyses.
Results
Three hundred and seventy-six (376) cases were reviewed.
The majority (59.0 %) were from rural addresses of which
79.3 % were from the practice of the country urologist.
There were significant differences in the origin of patients
utilizing the urology practices (p < 0.001). Of those seen
outside of KSA (298), approximately 25 % was urban-
dwelling in contrast to that of the Kingston-based urologist
where all were urban dwelling (Table 1).
Data on age were available for 97.3 % (366) of the cases.
Ages ranged from 45 to 88 years. The median age was 70
years (IQR =16). The modal age category was 70–79 years
(40.7 %); almost 1 in 3 persons were in the 60–69 age
group. Only 4 cases (1.1 %) were less than 50 years old.
When the data was disaggregated by rural–urban resi-
dence, there were statistically significant differences in age
distribution (Wilcoxon Rank Sum test; p = 0.034). Rural
men were typically older than urban men, the median ages
being 72 (IQR = 13) and 68.5 (IQR = 13) years respectively.
Similar findings were also noted by urological practice
setting with the country urologist seeing older patients
Fig. 1 Map of Jamaica showing the southwestern region with a population of 738,292 served by one fixed urologist
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when compared with the urologist in the city; (median age:
72 years versus 65 years).
Documented levels of PSA varied from 0.9 to 1841 ng/ml,
in a highly and positively skewed distribution. The
overall median PSA level was 19.0 (IQR = 36.4).
Rural-dwelling men typically had higher PSA levels at
presentation than urban men. Median PSA levels for
rural-dwelling men of 22.9 ng/ml (IQR =43.5) versus
18 ng/ml (IQR = 22.4) for urban-dwelling men were
observed. This difference was statistically significant
(Wilcoxon Rank Sum test; p = 0.001).
Approximately 30 % of men were classified on DRE
examination as having stage T1c disease, and slightly more
than a quarter of men as having T3 disease. 26.3 % of men
had T2 disease (16.3 % T2a and 10 % T2b) and 16.3 % had
stage T4 disease. By rural–urban distribution, there was a
statistically significant difference with regard to local stage
of disease at presentation. Disproportionately higher per-
centages of rural men presented with more locally-
advanced disease (χ2 = 15.02, df = 4, p = 0.005). While rural
men constituted 59 % of study participants, they comprised
65.2 % and 73.7 % of those with T3 and T4 disease
respectively.
Gleason scores ranged from 5–10, the overall mean score
being 6.99 (sd =0.89) (Fig. 2). Three quarters of the cases
(75 %) had scores in the 6–7 range, 17.8 % of cases had a
Gleason score of 8, 6 % had Gleason scores of 9 and 0.3 %
had Gleason scores of 10. High grade disease (Gleason score
8–10) accounted for 24.8 % of cases overall. Rural men
had a statistically significant higher mean Gleason
score than urban men (t =1.98, df =357, p = 0.048).
Figure 3 shows the distribution of the initial modes of
therapy pursued with patients. Androgen deprivation ther-
apy (ADT) (42 %) and bilateral orchidectomy (22 %) were
the most frequently employed therapies. About 1 out of
every 7 men received a combination of radiotherapy and
ADT as the initial therapy for locally advanced disease.
Watchful waiting and active surveillance (deferred treat-
ment) as well as patient-initiated herbal treatment to-
gether totaled less than 5 % of initial treatment instituted.
As initial therapy, significantly greater proportions of
Table 1 Patient characteristics [n, (%)]
Variable Categories Urban Rural
Respondents Total 154 (41.0 %) 222 (59.0 %)
Practice Urologist 1 78 (100) 0 (0)
Urologist 2 76 (25.5) 222 (74.5)
Age Group <50 2 (1.1) 2 ( 0.9)
50-59 29 (50.9) 28 (49.1)
60-69 58 (46.5) 61 (54.5)
70-79 53 (35.6) 96 (64.4)
80-89 15 (36.1) 29 (65.9)
DRE Stage T1 50 (53.3) 50 (46.2)
T2a 28 (49.1) 29 (50.9)
T2b 13 (36.1) 23 (63.9)
T3 32 (34.8) 60 (65.2)
T4 15 (26.3) 42 (73.7)
Fig. 2 Distribution of Gleason Scores
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rural-dwelling patients (27.3 %) had bilateral orchidecto-
mies than urban-dwelling patients (13.7 %) (χ2 = 9.2, df =
1, p = 0.002). In contrast, radical prostatectomy was more
common among urban-dwelling (20.1 %) than rural dwell-
ing men (5.6 %) Androgen deprivation therapy was equally
used for urban and rural dwelling men as initial therapy
(41.0 % and 42.6 % respectively).
By practice, the city-based urologist prescribed ADT
using LHRH analogues (32.8 %) and performed rad-
ical prostatectomy (31.3 %) at initial therapy com-
pared with the rural-based urologist where ADT
using LHRH (44.0 %) and bilateral orchidectomy
(24.4 %) were most frequently used.
In bivariate analyses, type of treatment was associated
with area of residence and with DRE tumour stage. DRE
tumour stage was also associated with area of residence.
This pointed to the potential for confounding of the
relationships observed. As type of treatment exhibited
multicollinearity with DRE tumour stage, only the latter
variable was used as a covariate in regression analysis.
A binary logistic regression model to identify independ-
ent predictors of rural/urban status was developed. Rural/
urban status was the outcome. Variables identified as asso-
ciated in bivariate analyses (PSA level, Age category, DRE
stage and Gleason score category) were entered as predic-
tors. Table 2 shows the results obtained.
Fig. 3 Initial Therapy at presentation
Table 2 Predictors of geographic (rural–urban) residence among respondents
Variable B S.E. p-value Odds Ratios (95 % C.I.)
PSA level .000 .001 .362 1.00(1.00-1.01)
DRE tumour stage categorya (locally-advanced/organ-confined ) .528 .254 ..038 1.70(1.03-2.79)
AGE
<50 (reference category)
50-59 -.085 1.051 .936 0.92(0.12-7.21)
60-69 .082 1.035 .937 1.09(0.14-8.23)
70-79 .491 1.031 .634 1.63(0.22-12.23)
80-89 .721 1.075 .502 2.05(0.35-16.9)
Gleason Score Category
Low (reference category)
Intermediate .251 .269 .350 1.29(0.76-2.18)
High .521 .335 .120 1.68(0.87-3.25)
First category is the reference category for categorical covariates
All reference categories were coded as ‘0’
aindicates statistically significant predictors in logistic regression model with these variables
Dependent variable coded as Rural = 1, Urban = 0 (reference)
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DRE stage was identified as the only significant independ-
ent predictor after controlling for age, Gleason score and
PSA levels. Subjects with disease extending beyond the
prostate (locally-advanced disease) were 1.7 times more
likely to be rural persons than to be urban dwellers (OR =
1.7, 95 % CI = 1.03 - 2.29).
Discussion
This study found that rural-dwelling men had a 70 %
higher risk of having locally advanced disease when
compared to urban-dwelling men based on DRE find-
ings and this was clinically and statistically significant.
It is likely that a lack of awareness of the disease, com-
paratively lower rural screening activity, diminished ac-
cess to readily available and affordable general medical
and specialist urologic care, and comparatively lower
economic means contributed to the observed results.
Rural-dwelling patients had a significantly greater num-
ber of bilateral orchidectomies as initial treatment which
is not only due to more advanced tumours but also reflect
differences in urologists’ practice preferences as well as
issues related to affordability and concerns with patient
compliance. Similarly, differences in rates of radical pros-
tatectomy was not simply a function of stage of disease,
but was influenced by access and availability with it being
more available in KSA. Hence, practice preferences rooted
in the local realities related to cost, access, and compliance
and limited follow-up are putative factors that help ex-
plain why orchidectomy may have been used for ADT in
rural men with advanced disease and LHRH analogues
was more frequently opted for by the city-based urologist.
When compared to the clinico-pathologic profiles of
PCa in Jamaican men described by Shirley et al. [9] and
Coard et al. [10] neither of whom differentiated between
rural and urban dwelling in a clinical series of men diag-
nosed and treated in Kingston, median PSAs of 37 ng/ml
and 30.7 ng/ml respectively were described which are
higher than the overall median PSA of 19 ng/ml and the
median rural PSA of 22.9 ng/ml in this study. These case
series included patients diagnosed between 1993 to 1997,
and 2000 to 2005 respectively. Secular trends of increased
and more widespread use of PSA-based screening and
greater awareness and understanding of the disease may
account for these differences. Overall, 56 % of men in this
study had localized disease (T1 and T2) on DRE compared
to 63 % in Shirley’s study. Aiken et al. reported in an earl-
ier study that 51 % of Jamaican men with newly diagnosed
PCa had localized disease [12]. The distribution of
Gleason scores in this study was similar to that reported
by Coard. Shirley’s study had an inexplicably high percent-
age of high grade cancers which is most unusual.
Cadmium, a putative risk factor for PCa [13], is known to
exceed the upper limits of safe levels in the soil in the par-
ishes of Manchester and St. Elizabeth, a known bauxite belt
[14, 15]. The concentration of cadmium found in yam
tubers grown in these soils is as high as 55 % of that present
in the soil and possibly 6.4 % is bioavailable on human con-
sumption [16]. It is therefore possible that the differences
seen in this study may be partly due to the cadmium levels
in the soil. However, this is highly speculative and would
require further study to verify an association locally.
Barriers to accessing urological care would have differen-
tially affected the rural patients and may partly account for
the differences observed. Geographic barriers exist due to
the very hilly rural terrain, poorly maintained roads, and
inconsistent transportation. Financial barriers to accessing
urological care in the country due to less medical insurance
coverage and absent or inconsistent income would also
account for the differences noted. For example the health
insurance coverage was 14 % in rural Jamaica versus 24 %
in the Kingston Metropolitan Area at the midpoint of the
period studied [17]. The single fixed country urologist
covers the southwestern region of the island with a
population of 738,000, whereas 12 urologists cover the
KSA region which has a population of 670,000 and
this contributes to the geographic maldistribution of
access to urological care in the Island [11].
Study limitations included not having a record of socio-
economic indices such as educational attainment which
may have confounded associations between location of
residence and indices of prognosis. PSAs were measured
by different laboratories, using different methods of assay,
and this could have introduced increased variability in the
PSA readings. This may contribute to a failure to detect
an association between PSA levels and rural–urban resi-
dence in statistical analyses. Misclassification of tumour
stage in local tumour stage assessment could arise due to
differences in the interpretation of DRE findings; however
this was minimized by combining the local DRE-based
staging into 2 broad categories.
Conclusion
Rural-dwelling men presented with more locally-advanced
prostate cancer compared to urban-dwelling men. Since
these men are generally of similar racial composition it is
likely that these disparities are due to differences in access
to care, screening practice and level of awareness of the
disease. Efforts to reduce the morbidity and mortality from
PCa in Jamaica must recognize these issues when public
health programs and clinical services are developed for
rural and urban clientele.
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